SEEd Medical Score for risk assessment in GIST according to the criteria developed by Miettinen and Lasota allows to estimate the risk of progressive disease and the risk of metastasis in patients with gastrointestinal stromal tumors using mitotic index, tumor size and tumor site as main prognostic factors.